In focus · trending topic

abuse deterrent technology

9 stories · following the connections

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology

By Nasdaq OMXMay 31, 2017, 11:32 AM UTC

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology

By Nasdaq OMXMay 31, 2017, 11:32 AM UTC

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology

By Nasdaq OMXMay 31, 2017, 11:32 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017

By Nasdaq OMXFeb 7, 2017, 1:01 PM UTC